^
BIOMARKER:

CBL mutation

i
Other names: CBL, c-Cbl, CBL2, RNF55, Cbl proto-oncogene, E3 ubiquitin protein ligase
Entrez ID:
Related biomarkers:
CBL mutation
MDS
ruxolitinib
Sensitive: A2 - Guideline
CBL mutation
AML
gilteritinib
Resistant: B - Late Trials
CBL mutation
AML
cytarabine/daunorubicin liposomal formulation
Resistant: C3 – Early Trials
CBL mutation
Sarcoma
MGCD516
Sensitive: C3 – Early Trials
CBL mutation
NSCLC
MGCD516
Sensitive: C3 – Early Trials
CBL mutation
Melanoma
MGCD516
Sensitive: C3 – Early Trials
CBL mutation
NSCLC
SU11274
Sensitive: D – Preclinical
CBL mutation
CMML
dasatinib
Sensitive: D – Preclinical